388870 — Pharos IBio Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩98bn
- KR₩90bn
Annual cashflow statement for Pharos IBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -31,471 | -17,062 | -8,858 | -10,560 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 24,285 | 8,107 | -6.58 | -381 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -484 | 193 | 767 | 811 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -7,319 | -8,184 | -7,413 | -9,327 |
| Capital Expenditures | -1,481 | -334 | -855 | -1,018 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -76.7 | -6,233 | 1,329 | 611 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -1,557 | -6,567 | 474 | -408 |
| Financing Cash Flow Items | -2 | — | — | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 17,635 | -271 | 18,805 | -31.5 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 9,005 | -15,000 | 11,776 | -9,228 |